13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC
ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 24 holding rows worth $176,039,000.
- Accession
- 0001085146-22-004130
- Filer
- CIK 1012622
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 24 entries on the cover page, a total value of $176,039,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $176,039,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOHAVEN LTD | G1110E107 | COM | 392,200 | $59,289,000 | thousands by filing date | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 499,263 | $35,687,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 305,629 | $21,345,000 | thousands by filing date | |
| OPKO HEALTH INC | 68375N103 | COM | 5,102,756 | $9,644,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 4,491,260 | $9,207,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,393,165 | $8,087,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 635,194 | $8,003,000 | thousands by filing date | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 8,403,926 | $7,374,000 | thousands by filing date | |
| FORIAN INC | 34630N106 | cs | 1,408,432 | $4,718,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 2,208,872 | $3,357,000 | thousands by filing date | |
| IMMUTEP LTD | 45257L108 | SPONSORED ADS | 1,557,325 | $2,429,000 | thousands by filing date | |
| IMMUNITYBIO INC | 45256X103 | COM | 315,322 | $1,567,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 100,000 | $1,100,000 | thousands by filing date | call |
| PROSHARES TR | 74347X831 | ULTRAPRO QQQ | 50,000 | $966,000 | thousands by filing date | |
| DERMTECH INC | 24984K105 | COM | 176,569 | $699,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 2,412 | $644,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 6,633 | $526,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 34,049 | $295,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 250,000 | $281,000 | thousands by filing date | call |
| ASPIRA WOMENS HEALTH INC | 04537Y109 | COM | 728,100 | $271,000 | thousands by filing date | |
| VELO3D INC | 92259N104 | COM | 65,000 | $256,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 150,000 | $146,000 | thousands by filing date | put |
| SPY | 78462F103 | SHS | 100,000 | $144,000 | thousands by filing date | put |
| AGENUS INC | 00847G705 | COM NEW | 165,600 | $4,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-22-004130 | this filing | 2022-11-14 | acceptance time not in the bulk data set |